FDA approves Ryoncil for steroid-refractory acute graft-versus-host after allo-HSCT Health News FDA approves Ryoncil for steroid-refractory acute graft-versus-host after allo-HSCT Elana Gotkine December 27, 2024 The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for treatment for...Read More
